COR — Cencora, Inc.

NYSE · Consumer Discretionary · Distributors · CIK 1140859 ·
Last close
$281.10
Market Cap
$54.69B
52W High
$328.26
52W Low
$244.26
ADV30
1,779,858
Next earnings
2026-08-05
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026
Dec 2025 85,932,016,000 3,072,071,000 1,016,381,000 559,647,000 78,361,214,000 1,753,122,000 76,265,246,000
Sep 2025 83,728,554,000 2,953,577,000 945,941,000 -339,704,000 76,590,112,000 4,356,138,000 74,843,027,000
Jun 2025 80,663,532,000 2,907,115,000 980,239,000 687,402,000 73,956,905,000 2,231,852,000 71,747,014,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$4,288,733,000
Investing CF
$-4,933,569,000
Financing CF
$-916,832,000
CapEx
$-681,464,000
Dividends Paid
$-452,709,000
Buybacks
$-50,000,000
EPS Diluted TTM
$13.04
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$6,967,358,000
Inventory
$24,078,494,000
Receivables
$25,979,920,000
ST Investments
EBIT TTM
$1,737,490,000
Pretax Income TTM
$1,417,873,000
Interest Exp TTM
$319,617,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$328,680,013,824
EBITDA
$5,300,438,016
Free Cash Flow
$-318,246,112
Enterprise Value
$67,794,087,936
Total Cash
$2,176,496,128
Total Debt
$15,092,111,360
Shares Out
194,561,060
Trailing EPS
$13.04
Book Value
$17.46
ROE
107.1%
ROA
3.5%
Div Yield
0.85%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Sep 2025 321,332,819,000 3,933,622,000 1,554,169,000 76,590,112,000 74,843,027,000 3,875,120,000
Sep 2024 293,958,599,000 3,156,949,000 1,509,120,000 67,101,667,000 66,314,925,000 3,484,685,000
Sep 2023 262,173,411,000 2,685,605,000 1,745,293,000 62,558,746,000 61,892,459,000 3,911,334,000
Sep 2022 238,587,006,000 2,753,510,000 1,698,820,000 56,560,616,000 56,489,343,000 2,703,088,000

TTM Snapshot

Revenues TTM
$282,740,057,000
NetIncome TTM
$1,858,608,000
OpCashFlow TTM
$0
Assets (Latest)
$76,590,112,000
Forward EPS
$19.79

Max Pain — expiry 2027-01-15

max pain strike: $330.00 · spot: $288.10 · call oi: 2,658 · put oi: 893
Expected Move to 2027-01-15: ±$59.85 (20.77%) — implied range $228.25$347.95 · ATM straddle on $290.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CAH CARDINAL HEALTH INC $53.61B $228.91
TEL TE Connectivity plc $59.27B $203.05
GWW W.W. GRAINGER, INC. $62.34B $1320.48
FERG Ferguson Enterprises Inc. /DE/ $45.39B $234.05
SYY SYSCO CORP $37.91B $79.28

News headlines (Yahoo Finance, 1h cache)

Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
2026-06-23 23:53 · Yahoo
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
2026-06-19 17:10 · Yahoo
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
2026-06-19 12:36 · Yahoo
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
2026-06-18 16:49 · Yahoo
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
2026-06-18 14:33 · Yahoo
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns
2026-06-18 12:00 · Yahoo
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
2026-06-17 12:55 · Yahoo
Cencora Launches Next-Generation Nucleus® Solution with Multi-Site Pilot Across Specialty Physician Practices
2026-06-17 12:00 · Yahoo
Cencora Announces Samantha Hammock as Chief Human Resources Officer
2026-06-15 20:15 · Yahoo
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?
2026-06-15 15:47 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-06-22 16:05:32 2026-06-18 Durcan Dermot Mark Dir P - Purchase 274.19 4000 1096760